Riskpilot← Back to searchSign inGet full accessMARINE BIOEXPLOITATION AS
ASActiveOrg 997290976Ullstindvegen 157, 9023 KrokelvdalenForskning og utviklingsarbeid innen bioteknologi · NACE 72110Est. 20110 employees
Revenue 2020
NOK 0
EBITDA margin
—
+72% vs 2019
Equity ratio
-9761.7%
Financial strength
Net profit 2020
NOK -15K
+82% vs 2019
| Revenue | NOK 0 | — |
| EBITDA | NOK -15K | +72% |
| Net profit | NOK -15K | +82% |
| Total assets | NOK 6K | -17% |
| Equity | NOK -576K | -3% |
| Employees | 0 | — |
Legal name
MARINE BIOEXPLOITATION AS
Org number
997290976
Legal form
Aksjeselskap
NACE code
72110 · Forskning og utviklingsarbeid innen bioteknologi
Founded
24. september 2011
Share capital
NOK 17 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Å konvertere underutnyttet marint råstoff, herunder biprodukter fra fiskeindustri, til høyverdige produkter for anvendelse i næringsmidler, nutrasøytika, kosmesøytika og farmasøytika. Virksomheten omfatter etablering av komplette verdikjeder fra råstoff til konsument, herunder teknologiutvikling, applikasjonsutvikling, dokumentasjon av helsemessige effekter og patentering. Selskapet skal kunne lisensiere/selge patentretter, delta i andre selskaper og prosjekter og hva hermed står i forbindelse.
Address
Ullstindvegen 157, 9023 Krokelvdalen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Revenue | 135 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −6 | −69 | −228 | −54 | −15 |
| Depreciation & amort. | −3 | −0 | −0 | −0 | −0 |
| EBIT | −9 | −69 | −228 | −54 | −15 |
| Net financials | −21 | −13 | −27 | −27 | 0 |
| Profit before tax | −30 | −82 | −255 | −81 | −15 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −30 | −82 | −255 | −81 | −15 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Total assets | 165 | 46 | 19 | 7 | 6 |
| Equity | −143 | −225 | −480 | −562 | −576 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 308 | 271 | 500 | 569 | 582 |
| Total debt | 308 | 271 | 500 | 569 | 582 |
EBITDA margin
-1481100.0%
This company
15.8%
Market median
-9374151% vs market
20162020
Equity ratio
-9761.7%
This company
38.2%
Market median
-25654% vs market
20162020
Return on equity
-1480900.0%
This company
18.4%
Market median
-8048470% vs market
20162020
Net profit margin
-1480900.0%
This company
8.1%
Market median
-18282816% vs market
20162020
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20162020
Debt / equity
1.01×
This company
0.62×
Market median
-63% vs market
20162020
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SH Deputy Member | Deputy Member | 2015 |
LE Deputy Member | Deputy Member | 2015 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2015 | |
| Chairman | 2015 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MARINE BIOEXPLOITATION AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Siv Hemsett | Deputy Member | 0 companies |
| Lars Erik Løvaas | Deputy Member | 0 companies |
| Erik Løvaas | Board of Directors | 0 companies |
| Astrid Holm | Chairman | 0 companies |